In vitro experiments, nano-curcumin was reported to support antitumor cells against pancreatic cancer through various pathways, including enhancing the expression of CD86 and driving DC maturation; significantly reducing the levels of various pro-inflammatory cytokines, such as TNF-α, IL-8, IL-6, IL-10, and IL-1 in activated T cells; and down-regulating IL-8 and up-regulating IFN-γ expression in CTLs (107, 108). Here, CXCL8 is linked to familial pancreatic carcinoma.